HealthEquity (HQY) Stock Forecast & Price Target

$103.68 -0.57 (-0.55%)

(As of 08:01 PM ET)

HealthEquity - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 13 Analyst Ratings

Sell
0

Hold
1

Buy
12

Based on 13 Wall Street analysts who have issued ratings for HealthEquity in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 1 has given a hold rating, and 12 have given a buy rating for HQY.

Consensus Price Target

$107.23
3.42% Upside

According to the 13 analysts' twelve-month price targets for HealthEquity, the average price target is $107.23. The highest price target for HQY is $130.00, while the lowest price target for HQY is $92.00. The average price target represents a forecasted upside of 3.42% from the current price of $103.68.

Get the Latest News and Ratings for HQY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for HealthEquity and its competitors.

HQY Analyst Ratings Over Time

Type	Current Forecast 11/26/23 to 11/25/24	1 Month Ago 10/27/23 to 10/26/24	3 Months Ago 8/28/23 to 8/27/24	1 Year Ago 11/26/22 to 11/26/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	7 Buy rating(s)
Hold	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$107.23	$103.83	$101.67	$84.14
Forecasted Upside	3.42% Upside	17.90% Upside	33.21% Upside	22.85% Upside
Consensus Rating	Moderate Buy	Buy	Buy	Buy

The Tesla Trade Is Back In Business (Ad)

If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.

Discover how to trade Tesla, simply follow this link here.

HQY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HQY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

HealthEquity Stock vs. The Competition

Type	HealthEquity	Medical Companies	S&P 500
Consensus Rating Score	2.92	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	2.86% Upside	27,006.23% Upside	7.66% Upside
News Sentiment Rating	Positive News See Recent HQY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/15/2024	The Goldman Sachs Group 2 of 5 stars	D. Roman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$108.00	+12.85%
11/14/2024	BTIG Research 2 of 5 stars		Boost Target	Buy ➝ Buy	$110.00 ➝ $130.00	+34.24%
11/13/2024	Bank of America 4 of 5 stars		Boost Target	Buy ➝ Buy	$100.00 ➝ $120.00	+24.21%
9/20/2024	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$105.00 ➝ $105.00	+31.60%
9/4/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$102.00 ➝ $103.00	+25.78%
9/4/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$105.00 ➝ $105.00	+28.28%
Get the Latest News and Ratings for HQY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.
9/4/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$92.00 ➝ $92.00	+18.19%
6/20/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$107.00 ➝ $110.00	+29.81%
6/7/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $105.00	+23.47%
6/5/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$95.00 ➝ $100.00	+19.90%
6/4/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$98.00 ➝ $104.00	+28.05%
4/2/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$86.00 ➝ $108.00	+31.39%
2/23/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$84.00 ➝ $104.00	+26.26%
12/7/2022	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$89.00 ➝ $94.00	+43.14%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 02:22 PM ET.

HQY Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for HealthEquity is $107.23, with a high forecast of $130.00 and a low forecast of $92.00.
: 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There is currently 1 hold rating and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HQY shares.
: According to analysts, HealthEquity's stock has a predicted upside of 3.42% based on their 12-month stock forecasts.
: HealthEquity has been rated by research analysts at Bank of America, Barrington Research, BTIG Research, Deutsche Bank Aktiengesellschaft, JMP Securities, Royal Bank of Canada, and The Goldman Sachs Group in the past 90 days.
: Analysts like HealthEquity more than other "medical" companies. The consensus rating score for HealthEquity is 2.92 while the average consensus rating score for "medical" companies is 2.80. Learn more on how HQY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Check out the $100 Challenge now

This page (NASDAQ:HQY) was last updated on 11/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthEquity (HQY) Stock Forecast & Price Target